Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk

被引：0
作者：
Yadong Wang
Haiyan Yang
Haiyu Wang
机构：
[1] Henan Center for Disease Control and Prevention,Department of Toxicology
[2] Zhengzhou University,Department of Epidemiology, School of Public Health
来源：
Breast Cancer Research and Treatment | 2015年 / 150卷
关键词：
Polymorphism; Breast cancer; Risk; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
With great interest, we read the recent article entitled “Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis” published online in Pabalan et al. (Breast Cancer Res Treat 137:553–558, 2013). This article suggests that overall summary estimates imply no associations but suggest susceptibility among carriers of the C47G polymorphism and Pro-Ser genotype in premenopausal women. The result is encouraging. Nevertheless, several key issues in this meta-analysis are worth noticing.
引用
收藏
页码：467 / 471
页数：4
相关论文
共 99 条
  • [1] Pabalan N(2013)Association between Breast Cancer Res Treat 137 553-558
  • [2] Jarjanazi H(2003) ( Hum Mutat 22 121-128
  • [3] Ozcelik H(2007)) polymorphisms and breast cancer risk: a meta-analysis PLoS One 2 e268-156
  • [4] Rutter JL(2010)Mutational analysis of the Breast Cancer Res Treat 121 147-388
  • [5] Smith AM(2006)-interacting genes ZNF350/ZBRK1 and Hum Genet 119 376-591
  • [6] Davila MR(2008)/ J Hum Genet 53 579-1241
  • [7] Sigurdson AJ(2006) among Nat Genet 38 1239-543
  • [8] Giusti RM(2006) and BMC Cancer 6 19-1575
  • [9] Pineda MA(2007)-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals BMC Cancer 7 83-5801
  • [10] Doody MM(2011)Tagging single nucleotide polymorphisms in the Breast Cancer Res Treat 126 539-undefined
12345678910